2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Keyword Index<br />
haplotype sharing analysis: C13.1<br />
haplotype: P06.030, P12.029<br />
Hardware: P15.05<br />
Hardy-Weinberg: P10.55<br />
Hb A2 NYU: P12.073<br />
Hb variant: P12.074<br />
HBA1, HBA2: P02.170<br />
HbA1c: P17.03<br />
HbD: P12.001<br />
HbF: P12.002<br />
HBOC: P06.040<br />
HCC: P06.041, P06.042<br />
HCM: P16.22<br />
HCV: P11.053<br />
H-disease: P02.178<br />
Headache: P09.049<br />
Health Care Needs Assessment: P01.32<br />
Health pr<strong>of</strong>essionals: P01.29<br />
Hearing impairment: C14.3, P12.075,<br />
P12.076<br />
Hearing loss: P02.043, P11.032, P12.077<br />
HEARING LOSSES: P12.046<br />
heart defects: P02.017<br />
Heart Development: C11.2, C12.1,<br />
P11.015<br />
Heart Failure: P16.12<br />
heart malformation: P02.005<br />
Heart Transplant: P16.12<br />
heart: P06.070, P09.013<br />
height: P08.49, S06.2<br />
HELLP syndrome: P05.14, P05.15<br />
Hemangioma: P02.092<br />
Hematological: C17.3<br />
hematopoietic stem cells: S12.2<br />
hemiatrophy: P03.108<br />
hemochromatosis: P02.044<br />
Hemodialysis: P03.042<br />
hemoglobine S: P02.109<br />
hemoglobinopathies: P12.074, P12.078<br />
Hemoglobinopathy: P01.40<br />
hemophilia A: P11.052, P12.079<br />
Hemophilia B: P12.080, P14.10<br />
hepatic lipoprotein metabolism: P09.003<br />
Hepatitis: P11.053<br />
hepatocellular carcinoma: P06.043,<br />
P06.088<br />
hepcidin: P12.094<br />
HER2/neu: P06.136<br />
Hereditary breast and ovarian cancer:<br />
P06.120<br />
Hereditary breast cancer: P06.121,<br />
P06.130<br />
Hereditary breast-ovarian cancer: P06.131<br />
Hereditary Diffuse Gastric Cancer:<br />
P06.044<br />
hereditary disorders: P02.045, P11.046<br />
HEREDITARY FOLATE<br />
MALABSORPTION: P13.24<br />
hereditary gastric cancer: P06.045<br />
Hereditary hearing loss: P08.34<br />
hereditary hemochromatosis: P02.181,<br />
P13.25<br />
Hereditary multiple exostoses: P02.046,<br />
P13.26<br />
Hereditary Nervous System Diseases:<br />
P10.37<br />
Hereditary Nonpolyposis Colorectal Cancer<br />
(HNPCC): P06.149<br />
Hereditary nonpolyposis colorectal cancer:<br />
P06.146<br />
hereditary optic atrophy: P12.082<br />
hereditary pathology: P03.109<br />
hereditary predisposition: P06.125<br />
Hereditary Sclerosing Poikiloderma <strong>of</strong><br />
Weary: P09.050<br />
Hereditary Spastic Paraplegia (HSP):<br />
P12.083, P12.084, P12.085<br />
herg: P06.174<br />
heritability: P10.85<br />
heroin dependence: P09.051<br />
heterogeneity: P08.35, P12.086, P12.107<br />
heterogeneous phenotype: P03.088<br />
heterogenous disorders: P11.054<br />
heteroplasmy: P05.39, P11.075<br />
HFE gene: P09.078<br />
HFE: P02.044, P12.072, P13.25, P17.52<br />
HGO mutations: P12.009<br />
HGSNAT: P13.41<br />
high resolution melting: P03.150, P06.132,<br />
P09.058, P11.055, P15.07<br />
high throughput: P11.092<br />
high-resolution melting analysis: P10.62,<br />
P11.056<br />
High-throughput Real-Time PCR: P10.79<br />
high-throuput sequencing: C01.3<br />
hip dislocation: P03.107<br />
Hirschsprung’s disease: C17.4, P03.148,<br />
P09.052, P10.38<br />
Histomorphometry: C08.2<br />
historical relics: C09.5<br />
HL-60: P06.175<br />
HLA Class I Diversity: P10.39<br />
HLA Class II Diversity: P10.39<br />
HLA polymorphisms: P10.40<br />
HLA: C09.1, P10.31, P11.101<br />
HLA-B27: P03.028<br />
HLA-C: P09.101<br />
HLA-DRB1 alleles: P08.57<br />
HMGA2: P03.072<br />
HMGCS2: P11.057<br />
HNPCC testing: P06.157<br />
HNPCC: P01.03, P06.147, P06.148,<br />
P06.150, P06.152, S13.2<br />
HNPP: P12.086<br />
holoprosencephaly: P02.047, P02.048,<br />
P02.089, P03.029, P12.147<br />
Holt-Oram syndrome: P02.049<br />
homer1: P17.54<br />
homocysteine: P17.27<br />
homocysteinemia: P13.47<br />
homogenization: P11.007<br />
Homologous recombination: P14.11<br />
homozygosity mapping: P08.55<br />
homozygosity: P08.07, P10.41<br />
homozyosity mapping: P16.04<br />
hormonal control: P17.07<br />
hotspot: P12.025<br />
HOXD cluster: P03.030<br />
HPGD: P02.157<br />
HPLC: P12.158<br />
HPRT1: P12.104<br />
HPV infection: P07.05<br />
HPV: P06.046, P11.058<br />
H-ras: P06.039<br />
HRM: P11.059, P11.060, P12.021<br />
HS-111: P12.002<br />
HSP: P02.202<br />
HSPC300: P06.100<br />
hTERC: P06.181<br />
hTERT: P06.175<br />
HTR3: P09.007<br />
HTR3C: P09.063<br />
HTRA2: P17.55<br />
<strong>Human</strong> cancer: S12.1<br />
<strong>Human</strong> coagulation factor IX: P14.10<br />
human cognitive abilities: P08.32<br />
<strong>Human</strong> genotoxicity: P03.024<br />
human inherited disease: C15.3<br />
human lymphocytes: P03.041<br />
human meiotic recombination: C09.3<br />
<strong>Human</strong> metaphase chromosomes:<br />
P03.024<br />
human myocardial infarction: P17.33<br />
human papillomavirus detection: P06.026<br />
human papillomavirus: P06.026<br />
human skin fibroblasts: P11.036<br />
human variation: C09.2<br />
<strong>Human</strong>: P02.099, P10.42<br />
Hungarian: P10.46<br />
Hungary: P02.125<br />
huntingtin: P10.43<br />
huntington disease gene: P10.43<br />
Huntington disease like 2: P12.089<br />
Huntington disease: P01.33<br />
Huntington Horea: P12.090<br />
Huntington: P12.087, P12.088<br />
Huntington’s disease: P12.091, P12.092<br />
hydranencephaly-hydrocephaly: P02.050